Sex-specific urinary biomarkers for diagnosing bipolar disorder

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Chen, Jian Jun ^a,c   Huang, Hua ^a,b,c   Zhao, Li Bo ^a,b,c   Zhou, De Zhi ^a,b,c   Yang, Yong Tao ^a,b,c   Zheng, Peng ^a,b,c   Yang, De Yu ^a,c   He, Peng ^a,c   Zhou, Jing Jing ^a,c   Fang, Liang ^a,c   Xie, Peng ^a,b,c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c CHONGQING KEY LABORATORY OF NEUROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYMANDELIC ACID; 4 HYDROXYPHENYLACETIC ACID; ACETIC ACID; ACETONE; ALANINE; ALPHA HYDROXYBUTYRATE; BIOLOGICAL MARKER; BUTYRIC ACID DERIVATIVE; CHOLINE; CITALOPRAM; CITRIC ACID; DIMETHYLAMINE; DIMETHYLGLYCINE; FLUOXETINE; FORMIC ACID; HIPPURIC ACID; ISOBUTYRIC ACID; LITHIUM SALT; MALONIC ACID; N METHYLNICOTINAMIDE; NICOTINIC ACID; OLANZAPINE; OXALOACETIC ACID; PAROXETINE; RISPERIDONE; TAURINE; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; HYDROXYBUTYRIC ACID; N-METHYLNICOTINAMIDE; NICOTINAMIDE;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; URINALYSIS; ADOLESCENT; ANALOGS AND DERIVATIVES; AREA UNDER THE CURVE; DISCRIMINANT ANALYSIS; METABOLISM; METABOLOME; URINE; YOUNG ADULT;

ACETONE; ADOLESCENT; ADULT; AREA UNDER CURVE; BIOMARKERS; BIPOLAR DISORDER; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; HYDROXYBUTYRATES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; NIACINAMIDE; OXALOACETIC ACID; ROC CURVE; YOUNG ADULT;

EID: 84919782644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115221     Document Type: Article

References (30)

1. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, et al. (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241-51.
2. Nierenberg AA, Kansky C, Brennan BP, Shelton RC, Perlis R, et al. (2013) Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development. Aust N Z J Psychiatry 47(1): 26-42.
3. Hirschfeld RMA, Lewis L, Vornik LA (2003) Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. Journal of Clinical Psychiatry 64: 161-174.
4. Oquendo M, Currier D, Mann J (2006) Prospective studies of suicidal behavior in major depressive and bipolar disorders: What is the evidence for predictive risk factors? Acta Psychiatrica Scandinavica 114: 151-158.
5. Nicholson JK, Lindon JC (2008) Systems biology: metabonomics. Nature 455: 1054-1056.
6. Yap IKS, Angley M, Veselkov KA, Holmes E, Lindon JC, et al. (2010) Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. Journal of proteome research 9: 2996-3004.
7. Yang J, Chen T, Sun L, Zhao Z, Qi X, et al. (2013) Potential metabolite markers of schizophrenia. Mol Psychiatry 18(1): 67-78.
8. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: A global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48: 653-83.
9. Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, et al. (2012) Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res 11: 1741-1748.
10. Zheng P, Wang Y, Chen L, Yang D, Meng H, et al. (2013) Identification and validation of urinary metabolite biomarkers for major depressive disorder. Molecular & Cellular Proteomics 12: 207-214.
11. Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, et al. (2008) Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Molecular Psychiatry 14: 269-279.
12. Sussulini A, Prando A, Maretto DA, Poppi RJ, Tasic L, et al. (2009) Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics. Analytical chemistry 81: 9755-63.
13. Zheng P, Wei YD, Yao GE, Ren GP, Guo J, et al. (2013) Novel urinary biomarkers for diagnosing bipolar disorder. Metabolomics 9(4): 800-808.
14. Grigoroiu-Serbanescu M, Nöthen MM, Ohlraun S, Propping P, Maier W, et al. (2005) Family history influences age of onset in bipolar I disorder in females but not in males. Am J Med Genet B Neuropsychiatr Genet 133B(1): 6-11.
15. Mackay CE, Roddick E, Barrick TR, Lloyd AJ, Roberts N, et al. (2010) Sex dependence of brain size and shape in bipolar disorder: An exploratory study. Bipolar Disorders 12: 306-311.
16. Bylesjö M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, et al. (2006) OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom 20: 341-351.
17. Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, et al. (2005) Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem 77: 517-526.
18. Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, et al. (2012) Urinary metabolite markers of precocious puberty. Mol Cell Proteomics 11: M111.011072.
19. Bradley AP (1997) The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern recognition 30: 1145-1159.
20. Ge Y, Sealfon SC, Speed TP (2008) Some step-down procedures controlling the false discovery rate under dependence. Statistica Sinica 18: 881.
21. Hilty DM, Kelly RH, Hales RE (2000) Diagnosis and treatment of bipolar disorder in pregnant women. Prim Care Update Ob Gyns 7(3):105-112.
22. Teatero ML, Mazmanian D, Sharma V (2014) Effects of the menstrual cycle on bipolar disorder. Bipolar Disord 16(1):22-36.
23. Sharma V (2009) Management of bipolar II disorder during pregnancy and the postpartum period- Motherisk Update 2008. Can J Clin Pharmacol 16(1): e33-e41.
24. Sharma V, Pope CJ (2012) Pregnancy and bipolar disorder: A systematic review. J Clin Psychiatry 73(11): 1447-55.
25. Jia HM, Feng YF, Liu YT, Chang X, Chen L, et al. (2013) Integration of 1H NMR and UPLC-Q-TOF/MS for a comprehensive urinary metabonomics study on a rat model of depression induced by chronic unpredictable mild stress. PLoS One 8(5): e63624.
26. Roiser JP, McLean A, Ogilvie AD, Blackwell AD, Bamber DJ, et al. (2005) The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacology 30(4): 775-85.
27. Farooqui AA, Horrocks LA, Farooqui T (2000) Glycerophospholipids in brain: Their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids 106(1): 1-29.
28. Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpe S (1998) Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr Scand 97(4): 302-8.
29. Chen JJ, Liu Z, Fan SH, Yang DY, Zheng P, et al. (2014) Combined Application of NMR- and GC-MSBased Metabonomics Yields a Superior Urinary Biomarker Panel for Bipolar Disorder. Scientific Reports 2014; 4: 5855.
30. Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, et al. The human urine metabolome. PLoS One 8: e73076.